Description
Premium GW-0742 Capsules: Industrial Grade PPARδ Agonist for Advanced Research
PRODUCT SPECIFICATIONS TABLE
| Attribute | Specification |
|---|---|
| Brand | biosynlab |
| Product Name | GW-0742 Capsules |
| IUPAC Name | 2-[4-[[2-[3-fluoro-4-(trifluoromethyl)phenyl]-4-methyl-1,3-thiazol-5-yl]methylsulfanyl]-2-methylphenoxy]acetic acid |
| Common Names | GW-0742, GW610742, PPARδ agonist |
| CAS Number | 317318-84-6 |
| Molecular Formula | C₂₁H₁₇F₄NO₃S₂ |
| Molecular Weight | 471.48 g/mol |
| Form | Gelatin Capsules |
| Capsule Dosage | 10mg per capsule |
| Pack Size | 30 capsules, 60 capsules, 90 capsules |
| Purity | ≥98.5% (HPLC) |
| Chemical Class | PPARδ Agonist / Metabolic Modulator |
| Appearance | White powder in clear gelatin capsules |
| Storage | 2-8°C, desiccated, light-protected |
| Packaging | Amber pharmaceutical bottle with desiccant |
| Shelf Life | 36 months when stored properly |
Premium GW-0742 Capsules – Laboratory Grade PPARδ Agonist
biosynlab delivers pharmaceutical-grade GW-0742 Capsules for sophisticated scientific research and analytical applications. As a premier supplier of PPARδ agonists and metabolic modulators to laboratories across the USA, United Kingdom, and European Union, we provide researchers with precisely dosed, high-purity compounds essential for reproducible experimental protocols and cutting-edge metabolic research.
Chemical Composition & Structure
GW-0742 (systematic name: 2-[4-[[2-[3-fluoro-4-(trifluoromethyl)phenyl]-4-methyl-1,3-thiazol-5-yl]methylsulfanyl]-2-methylphenoxy]acetic acid), also known as GW610742, is a potent and highly selective PPARδ (peroxisome proliferator-activated receptor delta) agonist developed by GlaxoSmithKline. This advanced compound features a unique chemical structure with a fluorinated phenyl-thiazole core linked via a methylsulfanyl bridge to a phenoxyacetic acid moiety. The molecular formula C₂₁H₁₇F₄NO₃S₂ yields a molecular weight of 471.48 g/mol.
As a next-generation PPARδ agonist, GW-0742 demonstrates exceptional selectivity for the PPARδ subtype over PPARα and PPARγ, distinguishing it from earlier compounds. This selectivity profile has made it a compound of significant interest in research examining lipid metabolism, endurance capacity, and metabolic disorders.
Capsule Advantages for Research
Our 10mg capsules offer distinct advantages for laboratory workflows:
- Precise Dosing: Each capsule contains exactly 10mg of active compound (±2% variance)
- Enhanced Stability: Encapsulation protects from oxidation and degradation
- Convenience: Pre-measured units eliminate weighing errors and contamination risks
- Documentation: Batch-coded for complete traceability and chain of custody
- Ease of Use: Simplified administration in research protocols
Research Applications
biosynlab GW-0742 Capsules serve as standardized reference materials for:
- PPARδ receptor pharmacology and selectivity studies
- Lipid metabolism and fatty acid oxidation research
- HDL cholesterol regulation studies
- Endurance capacity and skeletal muscle adaptation research
- Metabolic syndrome and insulin sensitivity studies
- Anti-inflammatory and cytokine modulation research
- Comparative studies with GW-501516 (Cardarine)
- Wound healing and tissue repair research
- Analytical method development (HPLC, LC-MS/MS)
- Forensic toxicology reference standards
Researchers utilize GW-0742 alongside other PPAR agonists including GW-501516, SR-9009, and AICAR to advance understanding of nuclear receptor-mediated metabolic regulation.
Quality Control & Analytical Verification
Every production batch undergoes rigorous multi-phase testing:
- HPLC Purity Analysis: ≥98.5% confirmed via reverse-phase chromatography
- NMR Spectroscopy: ¹H-NMR, ¹³C-NMR, and ¹⁹F-NMR structural confirmation
- Mass Spectrometry: ESI-MS molecular weight verification
- Uniformity of Dosage: USP <905> compliance testing
- Dissolution Testing: Characteristic release profile confirmation
- Residual Solvent Analysis: GC-HS detection <100ppm total
- Heavy Metals Screening: ICP-MS for Class 1 and 2 elements
- Microbial Testing: USP <61> / <62> compliance
Certificate of Analysis (COA) and Material Safety Data Sheet (MSDS) included with each order.
Geographic Markets & Logistics
biosynlab provides GW-0742 Capsules to research institutions globally:
🇺🇸 United States: 3-5 day delivery to California, Texas, Florida, New York, Illinois, Washington, Colorado, Oregon, Arizona, Massachusetts, Pennsylvania, Ohio, Georgia, North Carolina, Michigan, New Jersey, Virginia, Maryland, Indiana, Tennessee, Missouri, Wisconsin
🇬🇧 United Kingdom: 2-4 day express to London, Manchester, Birmingham, Glasgow, Edinburgh, Bristol, Liverpool, Leeds, Sheffield, Cardiff, Belfast, Newcastle, Nottingham, Southampton, Leicester, Coventry
🇪🇺 European Union: 3-6 day delivery to Amsterdam, Rotterdam, Berlin, Munich, Hamburg, Cologne, Frankfurt, Stuttgart, Paris, Lyon, Marseille, Barcelona, Madrid, Rome, Milan, Vienna, Prague, Warsaw, Budapest, Copenhagen, Stockholm, Oslo, Helsinki, Brussels, Dublin, Lisbon
🇨🇭🇳🇴 Other Europe: Switzerland, Norway
All shipments include tracking numbers, discrete plain packaging, and customs-compliant documentation.
Packaging & Presentation
- Primary: Pharmaceutical-grade gelatin capsules (size 00)
- Secondary: Amber glass pharmaceutical bottle with child-resistant cap
- Tertiary: Heat-sealed mylar barrier bag with silica gel desiccant
- Outer: Opaque padded mailer with no product identification
- Labeling: Product code, batch number, storage conditions, QR-linked COA
- Documentation: COA, MSDS, handling guidelines, storage recommendations
